Presentation of discovery data from the GRP78 inhibitor program at EFMC-ISMC 2016
Stockholm, 25 August 2016. Nuevolution AB (publ) (NUE.ST) will present discovery data from the GRP78 inhibitor program at EFMC-ISMC 2016 (EFMC International Symposium on Medicinal Chemistry) in Manchester, UK, on Tuesday 30 August. The poster presented by Nuevolution scientists is titled “Novel inhibitors of GRP78: Screening a challenging target using the Chemetics® screening platform”. The poster will be available for attendants of the symposium on Monday 29 August and is to be made available on www.nuevolution.com on 29 August at 8:30 CEST. The GRP78 inhibitor program is in hit-to-